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DNA demethylation pathways:
Additional players and regulators
Matthias Bochtler1)2), Agnieszka Kolano1) and Guo-Liang Xu3)
DNA demethylation can occur passively by ‘‘dilution’’ of
methylation marks by DNA replication, or actively and
independently of DNA replication. Direct conversion of 5-
methylcytosine (5mC) tocytosine (C),asoriginallyproposed,
does not occur. Instead, active DNA methylation involves
oxidation of the methylated base by ten-eleven trans-
locations (TETs), or deamination of the methylated or a
nearby base by activation induced deaminase (AID). The
modified nucleotide, possibly together with surrounding
nucleotides, is then replaced by the BER pathway. Recent
data clarify the roles and the regulation of well-known
enzymes in this process. They identify base excision repair
(BER) glycosylases that may cooperate with or replace
thymine DNA glycosylase (TDG) in the base excision step,
and suggest possible involvement of DNA damage repair
pathwaysother thanBERinactiveDNAdemethylation.Here,
we review these new developments.
Keywords:.5-carboxylcytosine; 5-formylcytosine;
5-hydroxymethylcytosine; 5-hydroxymethyluracil; active
DNA demethylation; AID; deamination; oxidation; TDG; TET
Introduction
DNA methylation in vertebrates is involved in multiple
processes, including the control of gene expression,
X-chromosome-inactivation, imprinting, and the silencing
of mobile genetic elements [1]. The importance of DNA
methylation is evident from the severe consequences of its
loss. Lack of the DNA maintenance methyltransferase Dnmt1
leads to death of differentiated cells within a few generations
in culture, in both murine and human cells [2]. At the
organismal level, Dnmt1 deficiency causes a delay in
development, and death in mid-gestation [3]. The de novo
methyltransferases DNMT3A and DNMT3B are not required for
the survival of cells in culture (at least not separately), but
Dnmt3b deletion causes embryonic lethality in the mouse.
Dnmt3a knockout mice are born, but die at about 4 weeks of
age [4].
DNA demethylation does not have such a clear role,
in part because many pathways may contribute and act
redundantly [5]. Due to the resilience of carbon-carbon
bonds, methylation was originally considered as an irrevers-
ible modification, which could only be altered through
dilution or de novo synthesis of DNA [6, 7]. However, it is now
clear that DNA methylation need not be passively “diluted”
through DNA replication, but can also be actively erased [8].
Active genome wide DNA demethylation is well documented
in the sperm-derived paternal pronucleus of the zygote
for rapid activation of zygotic transcription [9–11]. Locus-
specific active DNA demethylation is well documented in
post-mitotic cells in the adult brain [12, 13], and also during
cell fate changes [14].
One step conversion of 5-methylcytosine (5mC) to cytosine
(C) is unknown, and also unlikely because of the difficulty
of breaking non-activated carbon-carbon bonds. Pathways
that convert 5mC back to C in several steps without the
formation of nicks or double strand breaks in DNA have been
described, but are improbable in vivo [15–17]. All known in
vivo conversions of 5mC to C involve replacement of the
methylated nucleotide, at the cost of the creation of single
strand nicks. Unlike plants, animals do not seem to be able to
excise 5mC paired with G directly (except in the context of
excision of larger patches of DNA). Instead, the base (or a
nearby base) is always first modified, either by deamination,
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oxidation, or – according to models that now appear less
likely – a combination of both, followed by replacement of
the modified nucleotide (possibly together with surrounding
nucleotides [18, 19]). Most evidence points to the base excision
repair (BER) pathway [20–24], but its role in global DNA
demethylation has been challenged [25]. Alternative pathways
include nucleotide excision [26, 27] and non-canonical
mismatch repair [28]. Modified DNA bases can also contribute
to DNA demethylation by “dilution” of methylation during
DNA replication. 5-Hydroxymethylcytosine (5hmC) in the
template strand in the CpG context blocks methylation of
the newly synthesized strand by the maintenance methyl-
transferase DNMT1, and thus has the same effect as an
unmodified C in the parental strand [29]. In the following, we
first reviewmodifications to the 5mC base.We then discuss the
fates of the altered DNA bases.
DNA base modification is the first step
of active demethylation
Genetic data implicate AID in demethylation, but
the substrate is not clear
Activation induced deaminase (AID) deaminates cytosine to
uracil and to a lesser extent 5mC to thymine, by simple
hydrolysis. AID has been named for its role in class switch
recombination, hypermutation, and gene conversion in
activated B-cells [30, 31], mediated by its deaminase activity
against cytosines in DNA [32]. AID is mainly expressed in
lymphoid cells [33], and only scarcely and transiently in other
tissues [34], except in the context of malignancy [35–37].
Consistent with the expression pattern of Aid in germinal
centers, lack of Aid abrogates class switch recombination and
somatic hypermutation in the mouse [30]. In humans, AID
deficiency causes the autosomal recessive form of hyper-IgM
syndrome (HIGM2) [38]. Both the class switch recombination
and hypermutation defects can be explained without refer-
ence to DNA demethylation, but additional experiments
show that Aid deficiency may nevertheless impair DNA
demethylation.
Expression of Aid in embryonic stem (ES) cells [39] and the
role of Aid in demethylation during reprogramming experi-
ments involving ES or iPSC cells are controversial. In
heterokaryon experiments (involving the fusion of ES cells
and differentiated cells), two independent groups found that
Aid knockdown reduced the efficiency of reprogramming, and
impaired demethylation of promoters of pluripotency associ-
ated genes [39, 40], whereas a third group reported no
expression of Aid in ES cells and concluded that Aid was not
required for reprogramming [41]. Reports about the involve-
ment of AID in the generation of induced pluripotent stem
cells (iPSCs) are equally contradictory. The original report
concluded that AID was required early in reprogramming for
the demethylation of selected promoters of pluripotency
genes [42]. A second study corroborated AID involvement, but
found that the enzyme regulated the induction of pluripotency
first negatively and then positively [43]. Two further studies
concluded that Aid did not play any role in reprogram-
ming [44, 45] (Fig. 1).
Studies addressing the role of deamination in DNA
demethylation in animals have also not yet led to consensus
conclusions. A genetic study of methylation dynamics of
germinal center B-cells from mice convincingly supports
a role of the enzyme in DNA demethylation [46]. However,
the same authors found no effect of Aid on DNA methylation
levels when using cells in culture, in agreement with
the results of at least two other groups [47, 48]. A pathway
for DNA demethylation in zebrafish embryos involving
Gadd45a, Aid/Apobec, and Mbd4 (to excise G:T mispairs)
was proposed [49] based on a correlation between Aid/
Apobec levels and DNA demethylation activity. However,
the experimental findings have since been challenged [50].
Slightly higher levels of DNA methylation were found
in primordial germ cells of Aid null mice compared to
controls, but it was not demonstrated that the effect was
direct [51], and results may be influenced by different
genetic backgrounds of Aid deficient and control mice [47].
Demethylation in the mouse brain by linked deamination
and BER has been suggested based on the detection of a
complex of Tdg, Gadd45a, and Aid, but Aid activity on
5mC containing DNA could not be directly demonstrated [23]
(Fig. 1).
Many reports on a role of AID in demethylation are hard
to reconcile with prevailing views about AID expression
patterns. Moreover, they conflict with biochemical results,
particularly with the tacit assumption that AID acts directly on
the 5mC base. Several reports agree that AID deaminates C
much more efficiently than 5mC [52–54]. Zebrafish Aid is a
better 5mC deaminase than other orthologs, but still prefers
a C over a 5mC [55]. Moreover, AID works only on single
stranded DNA (after treatment with RNase to clear RNA-DNA
hybrids), but not on double-stranded DNA or RNA-DNA
heteroduplexes [56].
Several investigators have sought to resolve the difficulty
of poor AID activity toward 5mC by postulating the
involvement of alternative deaminases. At least one human
APOBEC3 paralog (3A, but not 3G) indeed deaminates
5mC in DNA faster than AID [57], but the single murine
APOBEC3 also discriminates against 5mC [52]. Some
prokaryotic methyltransferases can catalyze deamination
of Cs to uracils [58] and of 5mCs to thymines [59] in the
absence of S-adenosylmethionine (SAM), but mammalian
DNA methyltransferases are not known to catalyze this
reaction, either in vitro or in vivo. Moreover, the implication
of alternative deaminases does not explain the genetic data
that implicate specifically Aid and not deaminases in general
in DNA demethylation.
The conflicting genetic and biochemical data suggest that
AID acts indirectly. AID may deaminate C, not 5mC, and
“regional” repair may then lead to the replacement of
methylated cytidines by unmethylated ones in the vicinity [28,
60, 61] (Fig. 2). Themodel is appealing, because it is consistent
with both genetic and biochemical data. Moreover, deamina-
tion of C rather than 5mC avoids the formation of a legitimate,
but miscoding (and therefore highly mutagenic) DNA base
during DNA demethylation. For more detail, and additional
arguments for and against a deamination-based DNA
demethylation pathway, the reader is directed to other
reviews in the literature [62–64].
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Genetic and biochemical data implicate TETs in
DNA oxidative demethylation
Ten-eleven-translocation (TET) proteins are Fe(II)-dependent
dioxygenases that oxidize DNA using molecular oxygen and
a-ketoglutarate as co-substrates, generating oxidized DNA,
succinate, and carbon dioxide (CO2) as the co-products. TETs
act on modified cytosines. They convert 5mC to 5hmC [65, 66],
5hmC to 5-formylcytosine (5fC), and 5fC to 5-carboxylcytosine
(5caC) [67]. Simplistically speaking, TET enzymes split
molecular oxygen into oxygen atoms (with
two unpaired electrons and a carbene-
like tendency to insert into other bonds).
One oxygen atom inserts into succinic
semi-aldehyde, the formal product of
a-ketoglutarate decarboxylation, to form
succinate, the other into the 5-substituent
of the C-base, converting 5mC to 5hmC,
5hmC to 5fC (as a result of the equilibrium
between gem-diol and aldehyde by
dehydration/hydration), and 5fC to 5caC
(Fig. 3A). More realistic models of the
reaction mechanism of a-ketoglutarate-
dependent dioxygenases in general [68]
and of TETs in particular [69] agree that
oxygen is split while bound to the iron in
the TET active site. The iron resting state is
Fe(II). Reaction with oxygen leads to a
Fe(IV)¼O species involved in oxidizing the
DNA base (Fig. 3B).
TETs were originally identified in the
context of hematologic malignancies.
The first paralog, TET1, is named for the
karyotype aberration t(10;11)(q22;q23), that
creates a TET1-MLL fusion protein [70]. The
same study also showed that there are three
TET paralogs in humans, as was later found
to be true also for mouse and zebrafish. Xenopus has only Tet2
and Tet3, presumably due to lineage specific loss of Tet1.
Functional Tets have also been found in invertebrates [71], and
even in the protozoan Naegleria gruberi [72, 73], but not in
plants [74]. Tets are large multidomain proteins (typically in
excess of 1,000 amino acids). Tet1 consists of a CXXC domain,
a Cys-rich domain (distinct from the CXXC domain, which is
also cysteine rich), and a double stranded b-helix (DSBH)
domain, which is interrupted by a spacer of unknown
function. The Cys-rich and DSBH domains form the catalytic
domain harboring the dioxygenase activity.
The CXXC domain is involved in Tet
targeting. In the case of Tet2, the CXXC
domain is provided on a separate poly-
peptide chain termed IDAX, due to an
ancestral chromosomal gene inversion [75].
Tet3 occurs in several isoforms with and
without CXXC domain [76].
The link between TET activity and
demethylation is supported by both genetic
and biochemical data. As TETs oxidize 5mC,
they obviously reduce the level of 5mC, and
conversely, a loss of TETs causes hyper-
methylation [77]. This does not necessarily
imply that all oxidized nucleobases are
ultimately converted back to the unmodi-
fied ones. In the early embryo, 5hmC has
been shown to persist through the early
divisions [11]. Particularly in the brain,
5hmC levels are relatively high [78], and a
plethora of 5hmC reader proteins, with no
obvious connection to DNA repair, suggest
a role for 5hmC as an epigenomic mark in its
Figure 1. Evidence for and against deamination-based DNA demethylation. The experi-
ments in favor of and against AID involvement in DNA demethylation in germinal center
B-cells are not directly comparable, because both Hogenbirk et al. [47] and Fritz
et al. [48] only assessed the effect of the presence or absence of Aid in cell culture,
whereas Dominguez et al. [46] used ex vivo cells. In culture, Dominguez et al. also do not
observe AID dependent demethylation [46].
Figure 2. Indirect replacement of 5mC nucleotides. The reaction is initiated by
deamination of C (as shown) or 5mC (not shown). The base is then excised by UDG or
TDG, and a nick is created at the abasic site. Long patch DNA resynthesis leads to
replacement of 5mC nucleotides by unmodified nucleotides (shown with tilted bases).
Flap trimming and DNA ligation complete the demethylation reaction. In principle, a
similar resynthesis reaction could also occur after excision of oxidation based
demethylation intermediates. The NER [27, 130] and ncMMR [28] pathways may take
over the role of LP-BER in local DNA resynthesis in some circumstances.
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own right [79]. However, there is solid evidence for the entire
pathway from 5mC ultimately back to C [22, 80]. Recently, the
entire pathway has been reconstituted in vitro from defined
components [81]. TET knockout phenotypes are informative
and consistent with a demethylation defect.
Triple Tet knockout ES cells and murine embryonic
fibroblasts (MEFs) are viable, but have differentiation and de-
differentation defects [77, 82]. Triple Tet KO ES cells have
problems with teratoma formation, contribute poorly to
chimeric embryos, and cannot support embryonic develop-
ment [77]. MEFs have problems with de-differentiation under
the influence of defined reprogramming factors (related to the
original Yamanaka factors [83]). The defect was traced to an
impaired mesenchymal-to-epithelial transition (MET), and
could be rescued by overexpression of miRNAs that were
suppressed by the TET deficiency [82]. Conversely, TET
overexpression facilitates reprogramming. Tet1 can replace
Oct4 in the standard cocktail for iPSC induction [84], and
together with Oct4 suffices for iPSC generation in the absence
of other exogenous reprogramming factors [85]. The positive
effects of Tets on reprogramming and differentiation are likely
mediated by the control of the methylation state of regulatory
loci, particularly enhancers that need to be activated to bring
about cell-type changes [14, 86, 87].
In animals, Tet deletion has species-dependent effects. In the
mouse, deletion of Tet3 causes neonatal lethality. Germline-
specific ablation of Tet3 abolishes the appearance of oxidized
5mC derivatives in the paternal pronucleus [10]. However, the
consequences of Tet3 ablation from the oocyte are mild. Tet3
ablation reduces fertility, but surprisingly embryos from
mating of Tet3 null mothers and wild-type fathers show no
overt defects in pre-implantation development and are viable,
suggesting that demethylation of the paternal pronucleus is
not essential [88]. In the mouse, loss of either Tet1 or Tet2 is
compatible with embryonic and postnatal development [89,
90]. Double knockout of Tet1 and Tet2 leads to partly
penetrant mid-gestation abnormalities. Nevertheless, some
overtly normal mice are born, albeit with reduced fertility of
females [91]. Triple Tet KO mice exhibit defects already at the
gastrulation stage. The phenotype is akin to the Nodal gain of
function phenotype and probably due to hypermethylation of
the promoters and consequent decreased expression of the
Lefty genes that antagonize Nodal signaling [92]. In Xenopus,
Tet3 deficiency causes defects in eye and neural develop-
ment [93]. In zebrafish, Tet3 deficiency alone is inconsequen-
tial, but combined loss of Tet2 and Tet3 genes, or of all three
Tet genes, is incompatible with survival beyond the larval
period [94].
Impaired TET activity alone does not seem to cause
malignancies, but it clearly contributes, particularly in the
hematopoietic system. TETs were named for a translocation
affecting the TET1 gene, but the case for the involvement of
TETs in malignant transformation is now clearest for a
genetic loss of TET2 [95–97]. Interestingly, impaired TET
activity can play a role in malignancies also in the absence of
genetic alterations of TET genes. Perturbations of the
tricarboxylic acid cycle (TCA) lead to accumulation of genuine
Figure 3. TET-catalyzed oxidation reactions. A: Incorporation of
atomic oxygen into 5mC, 5hmC, and 5fC. C─H bonds for insertion
are marked red, and inserted oxygen atoms orange. Note that the
description is a gross simplification to keep track of reaction
substrates and products. B: Activation of molecular oxygen and
formation of the Fe(IV)¼O intermediate according to the currently
accepted model for the reaction.
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or aberrant TCA metabolites, which inhibit TETs, but also
other a-ketoglutarate-dependent dioxygenases [98, 99] (Fig. 4
and Box 1).
AID and TETs may cooperate, but are unlikely to
act on the same base
The clear evidence for the involvement of both AID and TETs
in DNA demethylation has led to suggestions that they may
act sequentially on the same DNA base [23]. In principle, AID
could act upstream or downstream of TETs. Models that AID
acts upstream require the formation of the legitimate DNA
base thymine as a demethylation intermediate and imply a
pathway that should be highly mutagenic. Moreover, they
have to be reconciled with the weak activity of AID on 5mC
(compared to C) [52]. Models that AID acts downstream
require the action of AID on 5hmC, 5fC, or 5caC, and conflict
directly with biochemical data on AID [52]. Moreover,
they are hard to reconcile with the observation that most
5-hydroxymethyluracil (5hmU) in the genome appears to be
formed by oxidation of T, not deamination of 5hmC (Fig. 5
and Box 2).
Nucleotide replacement is the second
step of active demethylation
Direct reversion of modified DNA bases to C
does not seem to occur in vivo
The products of C or 5mC deamination by AID can only be
resolved by repair (because deamination decreases similarity
to C and may affect base close to, but different from 5mC). In
contrast, at least some of the products 5mC oxidation could
in principle revert back to C. The search for enzymes that
could catalyze such reversion reactions has paradoxically led
to the DNAmethyltransferases. In vitro, thiol reagents and the
de novo mammalian DNA methyltransferases DNMT3a and
DNMT3b can convert 5hmC (with loss of formaldehyde) and
5caC (with loss of CO2) to C in the absence of the methyl donor
S-adenosylmethionine [15–17, 100]. De novo DNA methyl-
transferases are present both in the germline and in the
oocyte (judging from defects in germline development in
their absence [101–104]), but a role of these enzymes in
demethylation would require the improbable absence of SAM.
5caC decarboxylation activity has been reported for stem cell
nuclear extracts [105]. Orotidine 5-phosphate decarboxylase
(ODC) decarboxylates orotidine 5-phosphate (6-carboxy-
uridine 5-phosphate) very efficiently [106], but lacks activity
on 5caC containing DNA. The stem cell decarboxylase activity
therefore remains unconfirmed and its source unknown.
Thus, DNA repair appears to be the only in vivo pathway to
resolve DNA demethylation intermediates.
Various BER glycosylases are involved in the
nucleotide replacement step
Uracil, generated from C by deamination and mispaired with
guanine, can be excised by UNG2, SMUG1, TDG, and
MBD4 [107]. Thymine, generated by deamination of 5mC
andmispaired with guanine, is excised by TDG andMBD4. The
reactions are well documented in the context of somatic
hypermutation. In the case of Ung2 [61] and Tdg [28], there is
also evidence for the involvement of these reactions in the
removal of nearby 5mC bases, by either long patch base
excision or non-canonical mismatch repair.
In contrast to deamination products, oxidized methyl-
cytosine derivatives are not mispaired, at least when 5fC and
5caC are present in their dominant tautomeric forms [108,
109]. However 5caC:G pairs may resemble T:G mispairs when
5caC when 5caC adopts a minor and still debated [109, 110]
alternative tautomer [111]. 5fC and 5caC nucleotides also
resemble BER substrates in many other ways. As formyl and
carboxyl groups are electron-withdrawing, both 5fC and 5caC
nucleotides have weakened glycosidic bonds [110, 112] like
many other oxidatively and otherwise damaged DNA
nucleotides [113]. Base pairing is weaker for 5caC:G than for
C:G [112], presumably leading to a higher rate of spontaneous
flipping, as for many damaged DNA bases [114]. Weakened
glycosidic bonds and increased flipping rates suggest that 5fC
and 5caCmay be excised by BER glycosylases, and indeed, this
is the case (Fig. 6).
Thymine DNA glycosylase (TDG), a monofunctional DNA
glycosylase, has been named for its activity against T bases
arising from 5mC deamination mispaired to G. TDG was also
the first enzyme found to be able to excise 5fC and 5caC [20,
80]. Favorable interactions between TDG and the flipped 5caC
base [115], and faster excision of 5fC than T from pairs with
G [20] have prompted speculation that the “main” role of TDG
may be in DNA demethylation rather than in deamination
repair. Tdg is barely expressed in oocytes or zygotes (judging
from the RNA levels), and not required for demethylation of
the paternal pronucleus [116]. It is essential for MET [82],
which plays a role in somitogenesis and organogenesis (e.g.
Figure 4. Influence of small molecule metabolites on TET activity.
The TCA cycle is shown in highly simplified form, omitting enzymes
and metabolites without clear link to TET activity. The co-substrate
a-ketoglutarate and the positive regulators of TET activity are in
green, negative regulators are in red. Enzymes that have been (in
their mutant variants) implicated in TET inhibition are shown in blue.
Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH),
and fumarate hydratase (FH) have mitochondrial and cytoplasmic
isoenzymes, encoded by separate genes in the case of IDH.
Mutations in both the cytosolic and mitochondrial forms of IDH have
been implicated in TET dysregulation. Note that redox equivalents
generated in the TCA cycle may influence vitamin C status, and are
used in oxidative phosphorylation for the production of ATP, which
also affects TET activity.
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nephrogenesis, cardiogenesis, or hepatogenesis). The timing
of MET fits nicely with the appearance of a Tdg deficiency
phenotype around embryonic day 11.5 in the mouse [23, 117],
but causality remains to be established.
Nei-like 1 (NEIL1) and Nei-like 2 (NEIL2), both bifunctional
DNA glycosylases, excise oxidatively damaged pyrimidines
(5-hydroxycytosine, 5-hydroxyuracil, thymine glycol) and
purines chemically degraded to bases structurally resembling
damaged pyrimidines (hydantoins, formamidopyrimidines)
[118]. In several screens, NEIL1 or NEIL2 contributed to
reactivation of epigenetically silenced reporter plasmids,
although to a lesser extent than TDG [22, 119]. Leonhardt and
co-workers concluded that NEIL1 and NEIL2 could act
redundantly with TDG [22]. Niehrs and co-workers dispute
glycosylase activity on 5fC and 5caC containing DNA, and
suggest instead that TDG recruits NEIL1 or NEIL2 (instead of
APEX) to excise the (deoxy)ribonucleosides [119]. A physio-
logical demethylation process requiring either NEIL1 or NEIL2
remains to be discovered. Neil1 knockout (and heterozygotic)
mice develop metabolic syndrome, a combination of severe
obesity, dyslipidemia, fatty liver disease, and a tendency for
hyperinsulinemia [120], but none of the phenotypes has been
linked to a demethylation defect. Neil2 knockdown leads to
a neural crest phenotype in Xenopus [119] not seen in Neil2
deficient mice [121].
NEIL3 (unlike NEIL1 and NEIL2) is a monofunctional
glycosylase lacking b, d-lyase activity. Reports are either
inconclusive [21] or conflict on whether [22] or not [119] NEIL3
Box 1
Impaired 5mC oxidation contributes to
malignancies
Loss or reduction of TET function and reduced 5hmC
levels are clearly correlated with various malignancies,
particularly of the hematopoietic system. The TET1 gene
was first identified as a breakpoint of the t(10;11)(q22;q23)
translocation leading to a TET1-MLL fusion protein in a
group of patients with acute myelogenic leukemia
(AML) [70]. TET2 mutations are frequent in myeloid
malignancies, including myelodysplastic syndrome, acute
myelogenic leukemias, and particularly chronic myelo-
monocytic leukemias [95–97]. The link between the loss of
TET function and hematopoietic malignancies is at least in
part causal.
Mice with conditional loss of Tet2 (not only of both, but
also of a single allele) in hemotopoietic cells exhibit
progressive enlargement of the hematopoietic stem cell
compartment and eventual myeloproliferation in vivo [137].
Overall loss of Tet2 leads to a tendency to developmyeloid
malignancies over the time-course of a year [90]. Acute
loss of Tet3 in a Tet2 deletion background strongly
enhances this tendency, and results in aggressive myeloid
cancer [138]. Unexpectedly, combined loss of Tet1 and
Tet2 promotes B-cell, but not myeloid malignancies in
mice [139]. In zebrafish, loss of Tet2 causes erythroid
dysplasia and anemia [140], and myelodyspastic syn-
drome [141]. Reports on DNA methylation levels in TET
deficiency are contradictory. Some of the early studies
reportedparadoxical hypomethylation [75, 142], while other
data suggested mechanistically more plausible hyper-
methylation [143], particularly at enhancers. The common
theme of the TET deficiency related malignancies is a
failure of progenitor cells to mature. The defect is most
parsimoniously explained by silencing of genes required
for differentiation due to hypermethylation.
A reduction of TET activity may play a role in
malignancies in the absence of genetic alterations of the
TET genes. The TET co-substrate a-ketoglutarate is an
intermediate of the tricarboxylic acid (TCA) cycle and an
also ametabolite in amino acid synthesis (as the product of
transamination). Two genuine TCA metabolites, succinate
and fumarate, and the oncometabolite (R)-2-hydroxy-
glutarate inhibit TETs [144–146] and accumulate as result
of succinate dehydrogenase (SDH) [98], fumarate hydra-
tase (FH) [98], and isocitrate dehydrogenase (IDH1/IDH2)
deficiency [99]. Succinate, fumarate, and (R)-2-hydroxy-
glutarate all broadly inhibit a-ketoglutarate-dependent
dioxygenases, including the Jumonji histone demethy-
lases. Among other effects, they also cause histone
hypermethylation [147], demonstrating that TETs are not
the only mediators of the oncogenic properties of the di-
or tri-carboxylic acids (Fig. 4).
The antioxidant vitamin C, controversially hailed as an
anti-cancer dietary supplement [148], enhances TET
activity in vitro and in vivo [149–151], presumably because
it affects the redox state of the iron co-factor [152].
Vitamin C also facilitates reprogramming, which depends
in part on TETmediated DNA demethylation [82, 153, 154],
and enhances the effect of the hypomethylating drug
5-azacytidine in hepatocellular cancer cell lines [155].
Many investigators use ATP for TET dependent reac-
tions [149, 156], because it appears to enhance oxidation.
However, the mechanistic role of ATP in the dioxygenase
reaction is not understood, and it is not clear whether
the dependence reflects a link between the metabolic
state of cells and TET activity.
Figure 5. Possible pathways for generation and excision of 5hmU.
Suggestions that 5hmU may be a demethylation intermediate suffer
from the lack of a convincing candidate for the 5hmC deaminase.
TETs discriminate only imperfectly against T. Therefore, and because
of the vast excess of T over 5mC in the genome, enzymatic
oxidation of T to 5hmU can occur. Isotope tracer studies indicate
that this pathway is the main source of 5hmU in the genome [161],
which is subsequently excised by several BER pathway enzymes.
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can excise 5caC from DNA. Neil3 is highly expressed in the
mouse oocyte, the unfertilized ovum, and the zygote, but then
the expression falls strikingly after the zygote stage [122],
suggesting a possible involvement in zygotic DNA demethyl-
ation (together with UNG2, see below). Neil3 is also expressed
in the developing mouse brain, particularly in regions where
neurogenesis takes place [122]. Neil3 deficient mice are viable
and fertile, but exhibit a loss of neural progenitors [123],
pointing to a role of the enzyme in rapidly dividing cells,
rather than in active DNA demethylation.
Uracil DNA glycosylases occur in mitochondrial (UNG1)
and nuclear (UNG2) isoforms that are generated by alternative
splicing. The enzymes excise uracils arising from cytosine
deamination. Ung2 was recently identified in an unbiased
screen for glycosylases involved in TET-dependent gene
reactivation. In cultured cells, Ung2, but not an inactive Ung2
variant, prevented the accumulation of 5caC in genomic DNA
resulting from Tet2 (catalytic domain) overexpression [21].
The finding was unexpected, because in vitro UNG2 had
been reported to lack activity against 5caC containing
substrates [80]. Whether weak UNG2 activity in vitro against
5-carboxyuracil (5caU) containing DNA [21] explains the cell
culture data is not clear, because catalyzed conversion of 5caC
to 5caU has not been demonstrated yet. As Ung transcript
levels are high in the zygote and early embryo, a role of the
enzyme in DNA demethylation at this stage was tested. Ung
deficiency in the zygote impaired demethylation at some loci
(Nanog and Line1 elements, some maternally hypermethy-
lated regions), but did not perturb global levels of oxidized
5mC bases [21]. As Ung2 has also been reported to cooperate
with Aid in active demethylation in the zygote [61], it is not
clear whether loss of Ung impairs oxidation or deamination
based demethylation. Ung deficient mice have elevated levels
of uracil in DNA, but develop normally into adulthood with
no overt phenotype [124].
It is generally assumed that standard steps of BER [125]
operate downstream of glycosylase action in DNA demethyla-
tion. However, little attention has been paid to whether a
single or more nucleotides are replaced. For BER downstream
of AID, only long patch repair is productive for DNA
demethylation, if indeed AID deaminates Cs and not 5mCs.
For BER downstream of TETs, short and long patch repair
could be productive for demethylation. Short patch repair
with Polb alone has been reconstituted [81], but whether this
is the dominant pathway downstream of TETs in vivo is not
clear.
Other damage repair factors and pathways may
contribute
In addition to the BER pathway, other DNA damage repair
pathways may be involved in active DNA demethylation.
Gadd45a (growth arrest and DNA damage inducible)
participates in various pathways that affect genome integ-
rity [126, 127]. The gene was also identified in a screen for
factors involved in DNA demethylation, and its overexpres-
sion was reported to cause activation of methylation silenced
Box 2
Could 5fC and 5caC be off the main
demethylation pathway?
5fC and 5caC share many features with damaged DNA
bases (Fig. 6). They are rare, they inhibit basic trans-
actions on DNA such as transcription [132, 133], and they
stimulate repair (the BER pathway, the exonuclease
activity of replicative DNA polymerases [111]). Could
oxidation of 5hmC to 5fC and 5caC be a form of
DNA damage, the result of overshooting TET activity?
Thymine hydroxylase (thymine dioxygenase), another
a-ketoglutarate-dependent dioxygenase, also overshoots
[157],suggesting that dioxygenases in general may have a
problem to “cleanly” stop oxidation at the level of the
hydroxymethyl group. Could there be a pathway from
5hmC back to C, not involving 5fC or 5caC? In other
words, what could happen to the 5hmC base other than
further oxidation?
5hmC is chemically stable and resistant to all DNA
glycosylases that have been tested, but it may be
channeled to base excision repair by deamination to
5-hydroxymethyluracil (5hmU). A demethylation pathway
involving 5mC oxidation prior to deamination has indeed
been claimed for the mouse, based on the detection of a
complex of Gadd45a, Aid, and Tdg, and the finding that
Tdg has glycosylase activity on 5hmU [23]. It is also
supported by a requirement for both Aid and Tet1 for
demethylation of certain reporter constructs in ES cells.
Finally, 5hmU is excised efficiently by the SMUG1 [158],
MBD4 or TDG [23, 159] glycosylases and can also be
removed by non-canonical mismatch repair, at least when
the base is mispaired with G [28]. Glycosylase excision is
60-fold more efficient when 5hmU is paired with G than
when it is paired with A [160], suggesting that the pathway
may be dedicated to the removal of deamination products
of bases derived from C and rather than to the removal of
oxidation products of T (Fig. 5).
Nevertheless, a mixed oxidation/deamination pathway
remains doubtful unless a convincing deaminase is
discovered. AID activity on 5hmC nucleobases in DNA
has never been demonstrated. Instead, biochemical
studies have made a convincing case that 5hmC has
too much steric bulk in the C5 position of the pyrimidine
ring to be a substrate for AID [52, 53]. Moreover, isotope
tracer studies indicate that most 5hmU in the genome is
formed by Tet mediated oxidation of T and not by the
deamination of 5hmC [161]. The efficient excision of 5hmU
by several BER glycosylases therefore seems primarily
required to repair oxidative damage to T. Thus, on balance
current data speak against a mixed oxidation/deamination
pathway for active DNA demethylation, and support the
role of 5fC and 5caC as bona fide intermediates of
oxidative DNA demethylation.
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reporter constructs and global DNA demethylation [128].
Moreover, based on experiments in zebrafish, it was suggested
that Gadd45 acted in deamination based DNA demethyla-
tion [49]. Both studies have been challenged [50, 129], but the
involvement of Gadd45 proteins in active DNA demethylation
has been confirmed also in several other systems [13, 130].
It is not entirely clear which DNA demethylation pathways
are stimulated by Gadd45 proteins. Initial data pointed
to an involvement of Gadd45 in AID based DNA demethyla-
tion [49]. More recently, Gadd45a was shown enhance
oxidation based DNA demethylation [128]. Several DNA
repair pathways may be coopted by Gadd45 proteins.
Gadd45a interacts directly with the BER glycosylase TDG
and enhances oxidation based demethylation. The protein
also binds the NER 30-endonuclease XPG and cooperates with
it in demethylation [27].
Nucleotide excision repair (NER) repairs primarily bulkier
lesions than BER, or lesions that interfere with transcription
(TC-NER). At first sight, the formyl and carboxyl groups of 5fC
and 5caC appear too small to trigger NER. However, 5fC causes
DNA under-winding [108], like many DNA lesions that are
repaired by the nucleotide excision repair pathway [131]. 5fC
and 5caC in the template strand interfere with transcrip-
tion [132, 133], suggesting that they may initiate transcription
coupled nucleotide excision repair (TC-NER) [134] (Fig. 6).
Indeed, the NER 3-endonuclease XPG was shown to be
required for demethylation of a reporter in Xenopus oocytes.
Moreover, the NER factors XPA, XPG and XPF were shown to
be required for demethylation of an rRNA promoter, and it
was additionally shown that the catalytic activity of XPG
(and not just the XPG protein itself) was required for
demethylation [130].
Non-canonical mismatch repair (ncMMR) has also been
considered as a possible pathway for the repair step of DNA
demethylation. The process is normally geared towards the
removal of mismatches starting from a nick elsewhere in
the DNA, and leads to replacement of nucleotide patches
from the nick or DNA end to 150 nucleotides past the
mismatch site [135]. In a recent study, it
was demonstrated that uracils in DNA
could trigger the replacement of 5mC
nucleotides in DNA in a nick-dependent
manner [28]. Although the process com-
petes with BER for U:G mismatches, it is
appears to be enhanced by BER, because
UDG or TDG create the nicks at U sites that
are required to prime new DNA synthesis in
ncMMR [28]. Due to the role of U bases in
the process, ncMMR would appear to be
involved in AID dependent demethylation.
On the other hand, a report that MutSa
preferentially binds DNA with 5caC:G pairs
over unmodified DNA suggests possible
involvement of ncMMR in oxidation based
DNA demethylation [111], which has not
been corroborated in a functional assay
[28]. At present, the involvement of ncMMR
in DNA demethylation has not yet been
demonstrated in physiological circumstan-
ces, and it remains unclear how the
genome integrity hazards associated with the combined
action of AID and ncMMR could be avoided (Box 3).
Conclusions and outlook
All known pathways for active DNA demethylation that have
been shown to operate in vivo in animals (but not plants)
begin with DNA base modification and end with nucleotide
replacement.
The base modification step involves either AID catalyzed
deamination, or TET catalyzed oxidation. TET participation
in active DNA demethylation is supported by genetic and
biochemical data. The genetic evidence for a role of AID in
active DNA demethylation has been challenged, but remains
strong on balance, especially for B-cells. However, biochemi-
cal data argue clearly against AID acting directly on 5mC or its
oxidized derivatives. The apparent contradiction between
genetic and biochemical data for AID is likely caused by the
tacit assumption that AID acts on the modified base directly.
Instead, it now appears more likely that AID acts on an
unmodified C in the vicinity to trigger repair that involves
exchange of one or several 5mC nucleotides with unmodified C
nucleotides.
Nucleotide exchange downstream of base modification
seems to occur predominantly by the BER pathway in most
circumstances. If indeed AID deaminates in the vicinity of the
methylated nucleotide, but not at the methylated nucleotide,
then only LP-BER can be effective in active DNA demethyla-
tion. In contrast, oxidation based DNA demethylation could
be completed by either SP-BER or LP-BER. The main BER
glycosylases involved in the base excision step are UNG (for U)
and TDG (for U, T, 5fC and 5caC). For the excision of 5fC and
5caC, several BER glycosylases have been identified that may
cooperate with or replace TDG in some circumstances. In
addition to BER, NER and perhaps also ncMMRmay have roles
in the nucleotide exchange step of active DNA demethylation.
At present, neither the choice between BER and alternative
Figure 6. Features of 5fC and 5caC nucleotides shared with damaged DNA nucleotides,
and pathways involved in their replacement. The statements on weakened glycosidic
bonds and N3 hydrogen bonding for 5fC:G and 5caC:G pairs are based on the work of
Maiti et al. [110] and Dai et al. [112]. The figure shows only the major tautomers. 5caC
has to adopt a minor tautomeric form for 5caC:G pairs to resemble T:G mispairs [111].
M. Bochtler et al. Prospects & Overviews....
8 Bioessays 38: 0000–0000, 2016 The Authors BioEssays Published by WILEY Periodicals, Inc.
R
e
v
ie
w
e
s
s
a
y
s
repair pathways nor the choice of glycosylases operating
within the BER pathway are well understood, and is not
fully clear how the hazards of nucleotide replacement are
minimized in active DNA demethylation.
The likely involvement of LP-BER and NER and the
possible involvement of ncMMR blur the distinction between
active DNA demethylation (in the absence of DNA replication)
and passive DNA demethylation (in the presence of DNA
replication). The indirect active and passive DNA demethyla-
tion pathways are mechanistically similar, except that new
DNA synthesis is either local or global. Moreover, there are
now clear examples for simultaneous active and passive DNA
demethylation, for example in the pronuclei of the mamma-
lian zygote [116, 136]. Cooperation between active and passive
demethylation pathways may also be expected on theoretical
grounds. Parental DNA strands remain methylated after
DNA replication, and hemi-methylated DNA is in danger of
being remethylated by the ubiquitous maintenance methyl-
transferase Dnmt1. Therefore, active DNA demethylation may
“secure” the results of passive DNA demethyation.
Many interesting questions remain open: how are loci
targeted for demethylation? How is the choice between
different DNA demethylation pathways made? When is the
replacement of nucleotides initiated by AID, when by TETs? To
what extent do pathways other than BER (such as NER and
ncMMR) contribute to the DNA repair step of DNA demethyl-
ation? Which BER glycosylases are required for which
physiological demethylation events? How are detrimental
effects of active DNA demethylation on DNA integrity
minimized? Do some demethylation intermediates, particu-
larly 5hmC, function as epigenetic marks in their own right?
To what extent are the phenotypes of TET deficient animals
attributable to impaired demethylation, as opposed to a lack
of 5hmC? What are the respective contributions of impaired
DNA repair and demethylation to the phenotypes of BER
glycosylase knockouts? How do defects in genes involved in
DNA demethylation lead to the (mostly known, but diverse)
phenotypes in development and disease? Why do knockouts
of orthologous genes (or combinations of genes) cause
seemingly dissimilar phenotypes in different vertebrates, at
least in some cases? To what extent can defects be attributed
to the dysregulation of specific pathways? Will additional
links between metabolism (such as the tricarboxylic acid
cycle) and gene regulation by DNA demethylation emerge?
The field will stay fascinating.
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Box 3
Avoiding DNA damage from DNA
demethylation
Active DNA demethylation is hazardous. Some inter-
mediates may cause mutations (U and T from C and 5mC
deamination) or interfere with transcription (5fC, 5caC).
Moreover, uncoordinated introduction of nicks or gaps in
both DNA strands may even lead to DNA double strand
breaks. How these risks are minimized in the context of
active DNA demethylation is only partly understood.
The U and T intermediates of deamination based DNA
demethylation are mutagenic in the context of DNA
replication. Active DNA demethylation occurs (by definition)
in the absenceofDNA replication. In these circumstances, U
bases can always be identified as illegitimate, and T bases
(and notGbases in the opposite strand) are excisedby TDG,
so that the original and not a mutated sequence is restored.
The 5fC and 5caC intermediates of oxidation based
demethylation interfere with transcription [132, 133], and
resemble damaged DNA bases (Fig. 6). Their levels are
therefore kept low [78, 162]. Rapid elimination of 5fC and
5caC from the genome appears to be aided by physical
association between TET enzymes and BER glycosy-
lases [22]. Moreover, formation of 5fC and 5caC is slow
enough (rate constant about 1/h, five times slower than the
rate of 5hmC formation [69], in the case of TET2 [69]) that
TDG can keep up with this rate (Tdg excises 5fC or 5caC at
rates of 5/h and 1/h in the absence and presence of
product inhibition, respectively [119]). Biochemical recon-
stitution experiments support this conclusion [81].
Simultaneous base excision repair of sites that are
close together could potentially lead to double strand
breaks, which are much more deleterious to cells than
single strand nicks. Given the low levels of intermediates
generated by deamination or oxidation, repair in both
strands in close proximity is unlikely. However, fully
methylated CpG sites represent a special hazard, and
extra safeguards seem to be in place to prevent that both
DNA strands are processed simultaneously. 5hmC in a
CpG dinucleotide site blocks oxidation of 5mC in the other
strand [159]. Should 5mC bases at a CpG site be oxidized
simultaneously nonetheless, repair proceeds in a highly
coordinated manner to avoid double strand break forma-
tion [81]. Possible nucleotide replacement by NER or
ncMMR appears to be more hazardous than replacement
by BER, because nucleotide replacement tracts are longer
and therefore more likely to overlap unless such overlap
is actively prevented.
The combined action of AID and ncMMR (that is
implied by recent data [28]) appears to pose particularly
severe threats to genome integrity. Cooperation between
ncMMR and AID occurs physiologically in somatic hyper-
mutation (SHM) and class switch recombination (CSR)
[163]. In SHM, mutations are generated not only by
deamination, but also by the recruitment of a low fidelity
polymerase for the DNA resynthesis step of ncMMR [163].
In CSR, double strand breaks are generated by a
combination of AID and UNG2 dependent nicks in one
strand and DNA resynthesis in the other strand [163]. How
AID and ncMMR could cooperate in active DNA demethyl-
ation without these side effects is not clear.
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